Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'dopamine D-3 receptor' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 145 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ito, Y; Horie, S; Shindo, Y
      A novel [2+2] photodimerization of N-[(E)-3,4-methylenedioxycinnamoyl]dopamine in the solid state

      ORGANIC LETTERS
    2. Guttman, M; Jaskolka, J
      The use of pramipexole in Parkinson's disease: are its actions D-3 mediated?

      PARKINSONISM & RELATED DISORDERS
    3. Dziedzicka-Wasylewska, M; Ferrari, F; Johnson, RD; Mierau, J; Rogoz, Z; Skuza, G; Sokoloff, P
      Mechanisms of action of pramipexole: Effects on receptors

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    4. Betancur, C; Lepee-Lorgeoux, I; Cazillis, M; Accili, D; Fuchs, S; Rostene, W
      Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D-3 receptor deficient mice

      NEUROPSYCHOPHARMACOLOGY
    5. Levant, B; McCarson, KE
      D-3 dopamine receptors in rat spinal cord: implications for sensory and motor function

      NEUROSCIENCE LETTERS
    6. Hillefors, M; von Euler, G
      Pharmacology of [H-3]R(+)-7-OH-DPAT binding in the rat caudate-putamen

      NEUROCHEMISTRY INTERNATIONAL
    7. Mattingly, BA; Caudill, A; Abel, M
      Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    8. Zuch, CL; Cory-Slechta, DA
      Stimulus properties of 7-OH-DPAT versus auto- and postsynaptic receptor-specific doses of quinpirole

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    9. Blednov, YA; Stoffel, M; Chang, SR; Harris, RA
      GIRK2 deficient mice - Evidence for hyperactivity and reduced anxiety

      PHYSIOLOGY & BEHAVIOR
    10. Audinot, V; Newman-Tancredi, A; Millan, MJ
      Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTP gamma S versus [S-35]-GTP gamma S binding isotherms

      NEUROPHARMACOLOGY
    11. Weber, B; Schlicker, E; Sokoloff, P; Stark, H
      Identification of the dopamine autoreceptor in the guinea-pig retina as D-2 receptor using novel subtype-selective antagonists

      BRITISH JOURNAL OF PHARMACOLOGY
    12. Yoshikawa, T; Yoshida, N; Oka, M
      The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D-2, D-3 and 5-HT3 receptors antagonist

      BRITISH JOURNAL OF PHARMACOLOGY

    13. Tetrahydroisoquinololine derivatives as modulators of dopamine D-3 receptors

      EXPERT OPINION ON THERAPEUTIC PATENTS
    14. Dutta, AK; Neisewander, J; Fuchs, R; Reith, MEA
      Synthesis and characterization of novel derivatives of 2-aminotetralins: Development of highly selective derivatives for the D3 receptor

      MEDICINAL CHEMISTRY RESEARCH
    15. Scatton, B; Sanger, DJ
      Pharmacological and molecular targets in the search for novel antipsychotics

      BEHAVIOURAL PHARMACOLOGY
    16. Bordet, R; Ridray, S; Schwartz, JC; Sokoloff, P
      Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats

      EUROPEAN JOURNAL OF NEUROSCIENCE
    17. Petronis, A
      The genes for major psychosis: Aberrant sequence or regulation?

      NEUROPSYCHOPHARMACOLOGY
    18. Langer, O; Gulyas, B; Sandell, J; Laszlovszky, I; Kiss, B; Domany, G; Acs, T; Farde, L; Halldin, C
      Radiochemical labelling of the dopamine D-3 receptor ligand RGH-1756

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    19. Boulay, D; Depoortere, R; Perrault, G; Sanger, DJ
      Decreased locomotor activity after microinjection of dopamine D-2/D-3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: A D-3 receptor mediated effect?

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    20. Depoortere, R; Perrault, G; Sanger, DJ
      The D-3 antagonist PNU-99194A potentiates the discriminative cue produced by the D-3 agonist 7-OH-DPAT

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    21. von Euler, M; Pham, TM; Hillefors, M; Bjelke, B; Henriksson, B; von Euler, G
      Inhalation of low concentrations of toluene induces persistent effects on a learning retention task, beam-walk performance, and cerebrocortical size in the rat

      EXPERIMENTAL NEUROLOGY
    22. Kawanishi, Y; Tachikawa, H; Suzuki, T
      Pharmacogenomics and schizophrenia

      EUROPEAN JOURNAL OF PHARMACOLOGY
    23. Karasinska, JM; George, SR; El-Ghundi, M; Fletcher, PJ; O'Dowd, BF
      Modification of dopamine D-1 receptor knockout phenotype in mice lacking both dopamine D-1 and D-3 receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    24. Cussac, D; Newman-Tancredi, A; Sezgin, L; Millan, MJ
      The novel antagonist, S33084, and CR218,231 interact selectively with cloned and native, rat dopamine D-3 receptors as compared with native, rat dopamine D-2 receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    25. Heijtz, RD; Ogren, SO; Fuxe, K
      Ontogeny of the motor inhibitory role of dopamine D-3 receptor subtype in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    26. Boulay, D; Depoortere, R; Oblin, A; Sanger, DJ; Schoemaker, H; Perrault, G
      Haloperidol-induced catalepsy is absent in dopamine D-2 but maintained in dopamine D-3 receptor knock-out mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    27. Kaichi, Y; Nonaka, R; Hagino, Y; Watanabe, M
      Dopamine D-3 receptor binding by D-3 agonist 7-OH-DPAT (7-hydroxy-dipropylaminotetralin) and antipsychotic drugs measured ex vivo by quantitative autoradiography

      CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    28. Muhlbauer, B; Kuster, E; Luippold, G
      Dopamine D-3 receptors in the rat kidney: role in physiology and pathophysiology

      ACTA PHYSIOLOGICA SCANDINAVICA
    29. Menalled, LB; Dziewczapolski, G; Garcia, MC; Rubinstein, M; Gershanik, OS
      D-3 receptor knockdown through antisense oligonucleotide administration supports its inhibitory role in locomotion

      NEUROREPORT
    30. Levant, B; Garimelli, B; Shafer, RA; Merchant, KM
      Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotride

      NEUROPSYCHOPHARMACOLOGY
    31. GUREVICH EV; JOYCE JN
      DISTRIBUTION OF DOPAMINE D-3 RECEPTOR-EXPRESSING NEURONS IN THE HUMANFOREBRAIN - COMPARISON WITH D-2 RECEPTOR-EXPRESSING NEURONS

      Neuropsychopharmacology
    32. Tremblay, M; Rouillard, C; Levesque, D
      Dopamine D-3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain

      SYNAPSE
    33. Ukai, M; Tamoto, H; Tanaka, T; Kameyama, T
      Characterization of the dopamine D-3 receptor agonist R(+)-7-hydroxy-N, N-di-n-propyl-2-aminotetralin-induced hypo- and hypermotility in mice

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    34. Kawashima, N; Nakamura, A; Okuyama, S; Chaki, S; Tomisawa, K
      Effects of NRA0045, NRA0160, and NRA0215 on regional Fos-like immunoreactivity in the rat brain

      GENERAL PHARMACOLOGY
    35. Darmani, NA; Zhao, W; Ahmad, B
      The role of D-2 and D-3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew)

      JOURNAL OF NEURAL TRANSMISSION
    36. Obadiah, J; Avidor-Reiss, T; Fishburn, CS; Carmon, S; Bayewitch, M; Vogel, Z; Fuchs, S; Levavi-Sivan, B
      Adenylyl cyclase interaction with the D2 dopamine receptor family; Differential coupling to Gi, Gz, and Gs

      CELLULAR AND MOLECULAR NEUROBIOLOGY
    37. Jonsson, EG; Nimgaonkar, VL; Zhang, XR; Shaw, SH; Burgert, E; Crocq, MA; Chakravarti, A; Sedvall, GC
      Trend for an association between schizophrenia and D3S1310, a marker in proximity to the dopamine D3 receptor gene

      AMERICAN JOURNAL OF MEDICAL GENETICS
    38. Boulay, D; Depoortere, R; Rostene, W; Perrault, G; Sanger, DJ
      Dopamine D-3 receptor agonists produce similar decreases in body temperature and locomotor activity in D-3 knock-out and wild-type mice

      NEUROPHARMACOLOGY
    39. Sartania, N; Strange, PG
      Role of conserved serine residues in the interaction of agonists with D-3 dopamine receptors

      JOURNAL OF NEUROCHEMISTRY
    40. Hurd, YL; Keller, E; Sotonyi, P; Sedvall, G
      Preprotachykinin-A mRNA expression in the human and monkey brain: An in situ hybridization study

      JOURNAL OF COMPARATIVE NEUROLOGY
    41. Filteau, F; Veilleux, F; Levesque, D
      Effects of reciprocal chimeras between the C-terminal portion of third intracellular loops of the human dopamine D-2 and D-3 receptors

      FEBS LETTERS
    42. Zhang, K; Weiss, NT; Tarazi, FI; Kula, NS; Baldessarini, RJ
      Effects of alkylating agents on dopamine D-3 receptors in rat brain: selective protection by dopamine

      BRAIN RESEARCH
    43. Hillefors, M; von Euler, M; Hedlund, PB; von Euler, G
      Prominent binding of the dopamine D-3 agonist [H-3]PD 128907 in the caudate-putamen of the adult rat

      BRAIN RESEARCH
    44. Hillefors, M; Hedlund, PB; von Euler, G
      Effects of adenosine A(2A) receptor stimulation in vivo on dopamine D-3 receptor agonist binding in the rat brain

      BIOCHEMICAL PHARMACOLOGY
    45. Khroyan, TV; Fuchs, RA; Beck, AM; Groff, RS; Neisewander, JL
      Behavioral interactions produced by co-administration of 7-OH-DPAT with cocaine or apomorphine in the rat

      PSYCHOPHARMACOLOGY
    46. MORISSETTE M; GOULET M; GRONDIN R; BLANCHET P; BEDARD PJ; DIPAOLO T; LEVESQUE D
      ASSOCIATIVE AND LIMBIC REGIONS OF MONKEY STRIATUM EXPRESS HIGH-LEVELSOF DOPAMINE D-3 RECEPTORS - EFFECTS OF MPTP AND DOPAMINE AGONIST REPLACEMENT THERAPIES

      European journal of neuroscience
    47. JOHNSON CN; STEMP G; ANAND N; STEPHEN SC; GALLAGHER T
      PALLADIUM (0)-CATALYZED ARYLATIONS USING PYRROLE AND INDOLE 2-BORONICACIDS

      Synlett
    48. BANCROFT GN; MORGAN KA; FLIETSTRA RJ; LEVANT B
      BINDING OF [H-3]PD-128907, A PUTATIVELY SELECTIVE LIGAND FOR THE D-3 DOPAMINE-RECEPTOR, IN RAT-BRAIN - A RECEPTOR-BINDING AND QUANTITATIVE AUTORADIOGRAPHIC STUDY

      Neuropsychopharmacology
    49. TREMBLAY M; ROUILLARD C; LEVESQUE D
      THE ANTISENSE STRATEGY APPLIED TO THE STUDY OF DOPAMINE D-3 RECEPTOR FUNCTIONS IN RAT FOREBRAIN

      Progress in neuro-psychopharmacology & biological psychiatry
    50. GAEDT K; HOLTJE HD
      CONSISTENT VALENCE FORCE-FIELD PARAMETERIZATION OF BOND LENGTHS AND ANGLES WITH QUANTUM-CHEMICAL AB-INITIO METHODS APPLIED TO SOME HETEROCYCLIC DOPAMINE D-3-RECEPTOR AGONISTS

      Journal of computational chemistry
    51. SCHWARTZ JC; DIAZ J; BORDET R; GRIFFON N; PERACHON S; PILON C; RIDRAY S; SOKOLOFF P
      FUNCTIONAL IMPLICATIONS OF MULTIPLE DOPAMINE-RECEPTOR SUBTYPES - THE D-1 D-3 RECEPTOR COEXISTENCE/

      Brain research reviews
    52. DUBERTRET C; GORWOOD P; ADES J; FEINGOLD J; SCHWARTZ JC; SOKOLOFF P
      METAANALYSIS OF DRD3 GENE AND SCHIZOPHRENIA - ETHNIC HETEROGENEITY AND SIGNIFICANT ASSOCIATION IN CAUCASIANS

      American journal of medical genetics
    53. FLIETSTRA RJ; LEVANT B
      COMPARISON OF D-2 AND D-3 DOPAMINE-RECEPTOR AFFINITY OF DOPAMINERGIC COMPOUNDS IN RAT-BRAIN

      Life sciences
    54. BAKER LE; SVENSSON KA; GARNER KJ; GOODWIN AK
      THE DOPAMINE D-3 RECEPTOR ANTAGONIST PNU-99194A FAILS TO BLOCK (-7-OH-DPAT SUBSTITUTION FOR D-AMPHETAMINE OR COCAINE())

      European journal of pharmacology
    55. PRINSSEN EPM; KOEK W; KLEVEN MS
      COCAINE SENSITIZATION PREVENTS THE HYPOLOCOMOTOR EFFECTS OF HIGH BUT NOT LOW-DOSES OF PD-128,907

      European journal of pharmacology
    56. MAJ J; DZIEDZICKAWASYLEWSKA M; ROGOZ R; ROGOZ Z
      EFFECT OF ANTIDEPRESSANT DRUGS ADMINISTERED REPEATEDLY ON THE DOPAMINE D-3 RECEPTORS IN THE RAT-BRAIN

      European journal of pharmacology
    57. WITKIN J; GASIOR M; ACRI J; BEEKMAN M; THURKAUF A; YUAN J; DEBOER P; WIKSTROM H; DIJKSTRA D
      ATYPICAL ANTIPSYCHOTIC-LIKE EFFECTS OF THE DOPAMINE D-3 RECEPTOR AGONIST, (-PD-128,907())

      European journal of pharmacology
    58. FINKJENSEN A; NIELSEN EB; HANSEN L; SCHEIDELER MA
      BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF THE PREFERENTIAL DOPAMINE D-3RECEPTOR AGONIST CIS-8-OH-PBZI

      European journal of pharmacology
    59. Prinssen, EPM; Koek, W; Kleven, MS
      Cocaine sensitization prevents the hypolocomotor effects of high but not low doses of PD 128,907 (vol 355, pg 19, 1998)

      EUROPEAN JOURNAL OF PHARMACOLOGY
    60. LEVANT B; CROSS RS; PAZDERNIK TL
      ALTERATIONS IN LOCAL CEREBRAL GLUCOSE-UTILIZATION PRODUCED BY D-3 DOPAMINE RECEPTOR-SELECTIVE DOSES OF 7-OH-DPAT AND NAFADOTRIDE

      Brain research
    61. LEVANT B
      DIFFERENTIAL DISTRIBUTION OF D-3 DOPAMINE-RECEPTORS IN THE BRAINS OF SEVERAL MAMMALIAN-SPECIES

      Brain research
    62. SUZUKI M; HURD YL; SOKOLOFF P; SCHWARTZ JC; SEDVALL G
      D-3 DOPAMINE-RECEPTOR MESSENGER-RNA IS WIDELY EXPRESSED IN THE HUMAN BRAIN

      Brain research
    63. Mattingly, BA; Himmler, C; Bonta, T; Rice, LL
      Effects of selective dopamine D-1- and D-2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT

      PSYCHOPHARMACOLOGY
    64. KHROYAN TV; BAKER DA; FUCHS RA; MANDERS N; NEISEWANDER JL
      DIFFERENTIAL-EFFECTS OF 7-OH-DPAT ON AMPHETAMINE-INDUCED STEREOTYPY AND CONDITIONED PLACE PREFERENCE

      Psychopharmacology
    65. CLIFFORD JJ; WADDINGTON JL
      HETEROGENEITY OF BEHAVIORAL PROFILE BETWEEN 3 NEW PUTATIVE SELECTIVE D-3-DOPAMINE-RECEPTOR ANTAGONISTS USING AN ETHOLOGICALLY BASED APPROACH

      Psychopharmacology
    66. DALLOLIO R; RIMONDINI R; GANDOLFI O
      EFFECTS OF COMPETITIVE AND NONCOMPETITIVE NMDA RECEPTOR ANTAGONISTS ON BEHAVIORAL-RESPONSES INDUCED BY 7-OH-DPAT AND QUINPIROLE IN RATS

      Pharmacological research
    67. TREMBLAY M; ROUILLARD C; LEVESQUE D
      DOPAMINE D-3 RECEPTOR ANTISENSE REDUCES NEUROPEPTIDE MESSENGER-RNA LEVELS IN RAT NUCLEUS-ACCUMBENS

      NeuroReport
    68. WALLACE DR; BOOZE RM
      UP-REGULATION OF (-7-HYDROXY-N,N-DI-N-[H-3]PROPYL-2-AMINOTETRALIN BINDING FOLLOWING INTRACEREBROVENTRICULAR ADMINISTRATION OF A NITRIC-OXIDE GENERATOR())

      Neurochemical research
    69. DIAZ R; SOKOLOFF P; FUXE K
      CODISTRIBUTION OF THE DOPAMINE D-3 RECEPTOR AND GLUCOCORTICOID RECEPTOR MESSENGER-RNAS DURING STRIATAL PRENATAL DEVELOPMENT IN THE RAT

      Neuroscience letters
    70. PREGENZER JF; ALBERTS GL; BINIM W
      AGONIST-INDUCED [S-35] GTP-GAMMA-S BINDING IN THE MEMBRANES OF SPODOPTERA-FRUGIPERDA INSECT CELLS EXPRESSING THE HUMAN D3 DOPAMINE-RECEPTOR

      Neuroscience letters
    71. SINGH J; DESIRAJU T; RAJU TR
      DOPAMINE-RECEPTOR SUBTYPES INVOLVEMENT IN NUCLEUS-ACCUMBENS AND VENTRAL TEGMENTUM BUT NOT IN MEDIAL PREFRONTAL CORTEX - ON SELF-STIMULATIONOF LATERAL HYPOTHALAMUS AND VENTRAL MESENCEPHALON

      Behavioural brain research
    72. VESSOTSKIE JM; KUNG MP; CHUMPRADIT S; KUNG HF
      CHARACTERIZATION OF [I-125] S(-)5-OH-PIPAT BINDING TO DOPAMINE D-2-LIKE RECEPTORS EXPRESSED IN CELL-LINES

      Neuropharmacology
    73. THORN L; ASHMEADE TE; STOREY VJ; ROUTLEDGE C; REAVILL C
      EVIDENCE TO SUGGEST THAT AGONIST MODULATION OF HYPERLOCOMOTION IS VIAPOSTSYNAPTIC DOPAMINE D-2 OF D-3 RECEPTORS

      Neuropharmacology
    74. WEISS B; ZHANG SP; ZHOU LW
      ANTISENSE STRATEGIES IN DOPAMINE-RECEPTOR PHARMACOLOGY

      Life sciences
    75. JOYCE JN; GOLDSMITH SG; GUREVICH EV
      LIMBIC CIRCUITS AND MONOAMINE RECEPTORS - DISSECTING THE EFFECTS OF ANTIPSYCHOTICS FROM DISEASE PROCESSES

      Journal of Psychiatric Research
    76. JENSEN BS; LEVAVISIVAN B; FISHBURN CS; FUCHS S
      FUNCTIONAL EXPRESSION OF THE MURINE D-2, D-3 AND D-4 DOPAMINE-RECEPTORS IN XENOPUS-LAEVIS OOCYTES

      FEBS letters
    77. VARTY GB; HIGGINS GA
      INVESTIGATIONS INTO THE NATURE OF A 7-OH-DPAT DISCRIMINATIVE CUE - COMPARISON WITH D-AMPHETAMINE

      European journal of pharmacology
    78. SCHEIDELER MA; MARTIN J; HOHLWEG R; RASMUSSEN JS; NAERUM L; LUDVIGSEN TS; LARSEN PJ; KORSGAARD N; CRIDER AM; GHOSH D; CRUSE SF; FINKJENSEN A
      THE PREFERENTIAL DOPAMINE D-3 RECEPTOR AGONIST CIS-8-OH-PBZI INDUCES LIMBIC FOS EXPRESSION IN RAT-BRAIN

      European journal of pharmacology
    79. BARILI P; RICCI A; BALDONI E; MIGNINI F; AMENTA F
      PHARMACOLOGICAL CHARACTERIZATION AND AUTORADIOGRAPHIC LOCALIZATION OFA PUTATIVE DOPAMINE D-3 RECEPTOR IN THE RAT-KIDNEY

      European journal of pharmacology
    80. SIGALA S; MISSALE C; SPANO P
      OPPOSITE EFFECTS OF DOPAMINE D-2 AND D-3 RECEPTORS ON LEARNING MEMORYIN THE RAT

      European journal of pharmacology
    81. UKAI M; TANAKA T; KAMEYAMA T
      EFFECTS OF THE DOPAMINE D-3 RECEPTOR AGONIST, R(-7-HYDROXY-N,N-DI-N-PROPYL-2-AMINOTETRALIN, ON MEMORY PROCESSES IN MICE())

      European journal of pharmacology
    82. MILLAN MJ; GRESSIER H; BROCCO M
      THE DOPAMINE-D-3-RECEPTOR ANTAGONIST, (-S-14297, BLOCKS THE CATALEPTIC PROPERTIES OF HALOPERIDOL IN RATS())

      European journal of pharmacology
    83. KLEVEN MS; KOEK W
      DOPAMINE D-2 RECEPTORS PLAY A ROLE IN THE (-)-APOMORPHINE-LIKE DISCRIMINATIVE STIMULUS EFFECTS OF (-PD-128907())

      European journal of pharmacology
    84. CUDENNEC A; FAGE D; BENAVIDES J; SCATTON B
      EFFECTS OF AMISULPRIDE, AN ATYPICAL ANTIPSYCHOTIC WHICH BLOCKS PREFERENTIALLY PRESYNAPTIC DOPAMINE AUTORECEPTORS, ON INTEGRATED FUNCTIONAL CEREBRAL-ACTIVITY IN THE RAT

      Brain research
    85. SWARZENSKI BC; OMALLEY KL; TODD RD
      PTX-SENSITIVE REGULATION OF NEURITE OUTGROWTH BY THE DOPAMINE D-3 RECEPTOR

      NeuroReport
    86. RIETSCHEL M; NOTHEN MM; ALBUS M; MAIER W; MINGES J; BONDY B; KORNER J; HEMMER S; FIMMERS R; MOLLER HJ; WILDENAUER D; PROPPING P
      DOPAMINE D-3 RECEPTOR GLY(9) SER(9) POLYMORPHISM AND SCHIZOPHRENIA - NO INCREASED FREQUENCY OF HOMOZYGOSITY IN GERMAN FAMILIAL CASES/

      Schizophrenia research
    87. WANG W; HAHN KH; BISHOP JF; GAO DQ; JOSE PA; MOURADIAN MM
      UP-REGULATION OF D-3 DOPAMINE-RECEPTOR MESSENGER-RNA BY NEUROLEPTICS

      Synapse
    88. RUSSELL RN; MCBRIDE WJ; LUMENG L; LI TK; MURPHY JM
      APOMORPHINE AND 7-OH DPAT REDUCE ETHANOL INTAKE OF P AND HAD RATS

      Alcohol
    89. HURLEY MJ; STUBBS CM; JENNER P; MARSDEN CD
      D3 RECEPTOR EXPRESSION WITHIN THE BASAL GANGLIA IS NOT AFFECTED BY PARKINSONS-DISEASE

      Neuroscience letters
    90. TODD RD; CARL J; HARMON S; OMALLEY KL; PERLMUTTER JS
      DYNAMIC CHANGES IN STRIATAL DOPAMINE D-2 AND D-3 RECEPTOR PROTEIN ANDMESSENGER-RNA IN RESPONSE TO 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) DENERVATION IN BABOONS

      The Journal of neuroscience
    91. RICCI A; MAMMOLA CL; VEGA JA; ZACCHEO D; AMENTA F
      DENSITY AND PATTERN OF DOPAMINE D-2-LIKE RECEPTORS IN THE CEREBELLAR CORTEX OF AGED RATS

      Neurobiology of aging
    92. DAMASK SP; BOVENKERK KA; DELAPENA G; HOVERSTEN KM; PETERS DB; VALENTINE AM; MEADORWOODRUFF JH
      DIFFERENTIAL-EFFECTS OF CLOZAPINE AND HALOPERIDOL ON DOPAMINE-RECEPTOR MESSENGER-RNA EXPRESSION IN RAT STRIATUM AND CORTEX

      Molecular brain research
    93. ROTHSCHILD LG; BADNER J; CRAVCHIK A; GERSHON ES; GEJMAN PV
      NO ASSOCIATION DETECTED BETWEEN A D-3 RECEPTOR GENE-EXPRESSED VARIANTAND SCHIZOPHRENIA

      American journal of medical genetics
    94. MEYER ME
      MESOLIMBIC 7-OH-DPAT AFFECTS LOCOMOTOR ACTIVITIES IN RATS

      Pharmacology, biochemistry and behavior
    95. FERRARI F; GIULIANI D
      BEHAVIORAL-EFFECTS INDUCED BY THE DOPAMINE D-3 AGONIST 7-OH-DPAT IN SEXUALLY-ACTIVE AND SEXUALLY-INACTIVE MALE-RATS

      Neuropharmacology
    96. BRISTOW LJ; COOK GP; GAY JC; KULAGOWSKI JJ; LANDON L; MURRAY F; SAYWELL KL; YOUNG L; HUTSON PH
      THE BEHAVIORAL AND NEUROCHEMICAL PROFILE OF THE PUTATIVE DOPAMINE D-3RECEPTOR AGONIST, (-PD-128907, IN THE RAT())

      Neuropharmacology
    97. FISHBURN CS; BEDFORD M; LONAI P; FUCHS S
      EARLY EXPRESSION OF D-3 DOPAMINE-RECEPTORS IN MURINE EMBRYONIC-DEVELOPMENT

      FEBS letters
    98. KAMEI J; OHSAWA M
      EFFECTS OF DIABETES ON METHAMPHETAMINE-INDUCED PLACE PREFERENCE IN MICE

      European journal of pharmacology
    99. HURLEY MJ; STUBBS CM; JENNER P; MARSDEN CD
      DOPAMINE D-3 RECEPTORS ARE NOT INVOLVED IN THE INDUCTION OF C-FOS MESSENGER-RNA BY NEUROLEPTIC DRUGS - COMPARISON OF THE DOPAMINE D-3 RECEPTOR ANTAGONIST GR103691 WITH TYPICAL AND ATYPICAL NEUROLEPTICS

      European journal of pharmacology
    100. KOSHIKAWA N; MIWA Y; ADACHI K; KOBAYASHI M; COOLS AR
      BEHAVIORAL-EFFECTS OF 7-OH-DPAT ARE SOLELY DUE TO STIMULATION OF DOPAMINE D-2 RECEPTORS IN THE SHELL OF THE NUCLEUS-ACCUMBENS - JAW MOVEMENTS

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 03:28:39